The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2018

Filed:

Dec. 06, 2013
Applicant:

Alternative Gene Expression S.l., Madrid, ES;

Inventors:
Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 5/00 (2006.01); C12N 7/00 (2006.01); C12N 15/00 (2006.01); C12P 21/06 (2006.01); C12N 15/86 (2006.01); C07K 14/005 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/85 (2013.01); C07H 21/04 (2013.01); C12N 2502/00 (2013.01); C12N 2510/00 (2013.01); C12N 2710/14022 (2013.01); C12N 2710/14023 (2013.01); C12N 2710/14034 (2013.01); C12N 2710/14041 (2013.01); C12N 2710/14122 (2013.01); C12N 2710/14131 (2013.01); C12N 2710/14143 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01); C12N 2710/20051 (2013.01); C12N 2750/10022 (2013.01); C12N 2750/10034 (2013.01); C12N 2750/10051 (2013.01); C12N 2770/16022 (2013.01); C12N 2770/16034 (2013.01); C12N 2770/16051 (2013.01);
Abstract

The present invention may be included in the field of biotechnology and it covers the improved production of recombinant proteins in insect cells or insect larvae as biofactories by a novel expression cassette. This expression cassette comprises nucleic acid sequences such as promoters, homologous regions (hr) as enhancers, and sequences encoding transcriptional regulators, for example, the baculovirus Ac-ie-01 cDNA, or any combination thereof, which are able to increase the quality and production efficiency of the recombinant proteins. Moreover, the present invention is also directed to the vectors themselves comprising the above mentioned nucleic acid sequences of the invention, cells or insects infected, transformed or transfected with those sequences or vectors, and methods for producing the recombinant proteins by using the aforesaid sequences, vectors, cells or insects.


Find Patent Forward Citations

Loading…